Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 624001 - Provider product page
- Provider
- BioLegend
- Proper citation
- BioLegend Cat#624001, RRID:AB_2300550
- Product name
- Purified anti-Paxillin
- Antibody type
- Monoclonal
- Antigen
- Recombinant full length
- Description
- Paxillin (also known as peroxisomal membrane protein 3) is a cytoplasmic protein with LIM metal-binding repeat homology and LIM domains. There are three isoforms of this protein designated as α, β, γ; approximate molecular weight 68 kD. Paxillin is localized to actin-membrane attachment at sites of cell adhesion to extracellular matrix (focal adhesion). This protein undergoes cell adhesion-dependent tyrosine phosphorylation. Paxillin has been shown to interact with FAK, vinculin, src, Crk, p210BRC / ABL, talin, and integrin-β1. The PAX227 monoclonal antibody recognizes human and mouse paxillin and has been shown to be useful for Western blotting.
- Reactivity
- Human, Mouse
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 50 µl
- Storage
- Upon receipt, store frozen at -20° C.
Submitted references Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.
Fibronectin promotes tyrosine phosphorylation of paxillin and cell invasiveness in the gastric cancer cell line AGS.
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.
Heinhuis B, Koenders MI, van den Berg WB, Netea MG, Dinarello CA, Joosten LA
The Journal of biological chemistry 2012 Feb 17;287(8):5733-43
The Journal of biological chemistry 2012 Feb 17;287(8):5733-43
Fibronectin promotes tyrosine phosphorylation of paxillin and cell invasiveness in the gastric cancer cell line AGS.
Li D, Ding J, Wang X, Wang C, Wu T
Tumori 2009 Nov-Dec;95(6):769-79
Tumori 2009 Nov-Dec;95(6):769-79
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.
Yao H, Dashner EJ, van Golen CM, van Golen KL
Oncogene 2006 Apr 13;25(16):2285-96
Oncogene 2006 Apr 13;25(16):2285-96
No comments: Submit comment
No validations: Submit validation data